It does not affect blood glucose levels and is preferable to NSAIDs for many patients, particularly those with cardiovascular risk factors or kidney disease, which are common comorbidities in diabetes
Tirzepatide commonly causes nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during dose escalation
With medical oversight, dosing is gradually increased to minimize side effects while maximizing fat loss
Losing muscle is a common side effect of weight loss in adults with obesity and may negatively affect metabolism and bone health
Inform Your Travel Companions If traveling with others, let them know youre carrying injectable medication and may need to take injections during the trip
Rita Kapoor help patients understand what to expect from semaglutide GLP-1 therapy and guides them through a personalized weight management plan